Verapamil and indomethacin attenuate endotoxin-induced anorexia

Physiology & Behavior
W LanghansE Scharrer


To characterize the mechanism of the anorexia during infection, we investigated the effect of E. coli lipopolysaccharide (LPS) on feeding in rats under various conditions: LPS (125, 100, 75, and 50 micrograms/kg body weight = b. wt.) injected intraperitoneally (IP) reduced food intake by decreasing meal frequency without affecting meal size. The Ca++-channel blocker verapamil (5 mg/kg b. wt., IP) or the antipyretic and antiphlogistic drug indomethacin (2.5 mg/kg b. wt., IP), but not combined alpha- and beta-adrenergic receptor blockade by IP phentolamine plus propranolol (500 micrograms/kg b. wt., each) attenuated the anorectic effect of LPS (125 or 100 micrograms/kg b. wt.). The results suggest that a phospholipase A2-sensitive mechanism contributes to the anorexia during injection.


Jun 9, 1988·The New England Journal of Medicine·H R MichieD W Wilmore
Mar 1, 1985·Physiology & Behavior·W LanghansE Scharrer
May 1, 1986·The New England Journal of Medicine·H Rasmussen
May 1, 1988·Trends in Pharmacological Sciences·M Martin, K Resch
Mar 1, 1988·The Journal of Experimental Medicine·K J TraceyA Cerami
Jun 1, 1988·The Journal of Experimental Medicine·S H SocherD Martinez
Nov 29, 1984·The New England Journal of Medicine·C A Dinarello
Jul 16, 1980·Biochemical and Biophysical Research Communications·B A JakschikM M Steinhoff
Jan 1, 1984·Microbiology and Immunology·S SakaguchiO Sakaguchi
Nov 1, 1981·Pharmacology, Biochemistry, and Behavior·A S Levine, J E Morley
Aug 1, 1981·Physiology & Behavior·C A BaileC A Catanzaro

❮ Previous
Next ❯


Feb 1, 1992·Physiology & Behavior·L S Crnic, M A Segall
Aug 1, 1992·Physiology & Behavior·D O McCarthy, J M Daun
Jan 1, 1993·Physiology & Behavior·R W JohnsonK W Kelley
Feb 1, 1995·Physiology & Behavior·M S ExtonM G King
Sep 1, 1995·Physiology & Behavior·M S ExtonA J Husband
Jun 23, 2001·Pharmacology, Biochemistry, and Behavior·H Tsushima, M Mori
Apr 2, 2003·Pharmacology, Biochemistry, and Behavior·Claudia von MeyenburgBrian J Hrupka
Feb 23, 2000·Pharmacology, Biochemistry, and Behavior·A H Swiergiel, A J Dunn
May 1, 1996·The Journal of Clinical Investigation·C GrunfeldK R Feingold
Apr 17, 2010·Physiology & Behavior·Lori Asarian, Wolfgang Langhans
Dec 9, 2008·Physiology & Behavior·Gregory W SkinnerLois M Harden
Feb 6, 2007·Progress in Lipid Research·Alexandre A Steiner, Andrej A Romanovsky
Sep 23, 2008·The Journal of Comparative Neurology·Christoph RummelGiamal N Luheshi
Apr 9, 2011·Journal of Cachexia, Sarcopenia and Muscle·Theodore P Braun, Daniel L Marks
Jan 12, 2013·Brain, Behavior, and Immunity·Johan RuudAnders Blomqvist
Apr 30, 2011·Pharmacology, Biochemistry, and Behavior·Brigitte S KopfLori Asarian
Jul 5, 2016·Brain, Behavior, and Immunity·Anna NilssonAnders Blomqvist
Mar 12, 2009·Physiology & Behavior·Emilie PecchiJean-Denis Troadec
Apr 8, 2017·Prostaglandins & Other Lipid Mediators·Tetsuya TachibanaMark A Cline
Jan 30, 2007·Journal of Psychopharmacology·Laura Mattioli, Marina Perfumi
Dec 1, 2010·Nature Reviews. Endocrinology·Tomoyuki Furuyashiki, Shuh Narumiya
Jan 13, 2006·International Review of Psychiatry·Lori Asarian, Wolfgang Langhans
Jul 20, 2007·The Proceedings of the Nutrition Society·Wolfgang Langhans
Sep 14, 2002·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·F LugariniW Langhans
Feb 8, 2002·American Journal of Physiology. Endocrinology and Metabolism·Paulette M JohnsonLouis J Muglia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.